RU2022111461A - SODIUM BENZOATE CO-CRYSTALS AND THEIR APPLICATIONS - Google Patents
SODIUM BENZOATE CO-CRYSTALS AND THEIR APPLICATIONS Download PDFInfo
- Publication number
- RU2022111461A RU2022111461A RU2022111461A RU2022111461A RU2022111461A RU 2022111461 A RU2022111461 A RU 2022111461A RU 2022111461 A RU2022111461 A RU 2022111461A RU 2022111461 A RU2022111461 A RU 2022111461A RU 2022111461 A RU2022111461 A RU 2022111461A
- Authority
- RU
- Russia
- Prior art keywords
- crystal
- component
- disorder
- sodium benzoate
- radiation
- Prior art date
Links
- 235000010234 sodium benzoate Nutrition 0.000 title claims 11
- 239000004299 sodium benzoate Substances 0.000 title claims 11
- WXMKPNITSTVMEF-UHFFFAOYSA-M Sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 title 1
- 201000010099 disease Diseases 0.000 claims 11
- -1 sodium benzoate compound Chemical class 0.000 claims 10
- 229940075582 Sorbic Acid Drugs 0.000 claims 8
- 238000000634 powder X-ray diffraction Methods 0.000 claims 8
- 235000010199 sorbic acid Nutrition 0.000 claims 8
- 239000004334 sorbic acid Substances 0.000 claims 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 6
- WBYWAXJHAXSJNI-VOTSOKGWSA-N (2E)-3-phenylprop-2-enoic acid Chemical group OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 claims 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims 4
- 229960003512 nicotinic acid Drugs 0.000 claims 4
- 235000001968 nicotinic acid Nutrition 0.000 claims 4
- 239000011664 nicotinic acid Substances 0.000 claims 4
- WSWCOQWTEOXDQX-UHFFFAOYSA-N sorbic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 claims 4
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000004452 carbocyclyl group Chemical group 0.000 claims 3
- 230000004153 glucose metabolism Effects 0.000 claims 3
- 230000037356 lipid metabolism Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000005418 aryl aryl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000000627 niacin group Chemical group 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 1
- 206010057666 Anxiety disease Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 206010003736 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010004938 Bipolar disease Diseases 0.000 claims 1
- 208000006093 Closed Head Injury Diseases 0.000 claims 1
- 206010057668 Cognitive disease Diseases 0.000 claims 1
- 206010070976 Craniocerebral injury Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 208000009576 Hypercholesterolemia Diseases 0.000 claims 1
- 206010062060 Hyperlipidaemia Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010061536 Parkinson's disease Diseases 0.000 claims 1
- 201000006287 attention deficit hyperactivity disease Diseases 0.000 claims 1
- 201000007185 autism spectrum disease Diseases 0.000 claims 1
- 150000001875 compounds Chemical group 0.000 claims 1
- 201000003723 learning disability Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 201000008430 obsessive-compulsive disease Diseases 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
Claims (27)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/349,578 | 2016-06-13 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2019100436A Division RU2771810C2 (en) | 2016-06-13 | 2017-06-13 | Sodium benzoate cocrystals and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2022111461A true RU2022111461A (en) | 2022-05-12 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201370184A1 (en) | Heteroaryl Derivatives | |
HRP20210388T1 (en) | Crystalline polymorph of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | |
AR122395A2 (en) | CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-IL-PHENYL)-N4-[2-(PROPAN-2-SULFONYL)-PHENYL]-PYRIMIDIN-2,4 -DIAMINE | |
HRP20210507T1 (en) | Substituted 5-fluoro-1h-pyrazolopyridines in crystalline form | |
HRP20171848T1 (en) | Use of malononitrilamides in neuropathic pain | |
HRP20180303T1 (en) | Substituted 2-azabicycles and their use as orexin receptor modulators | |
BR112016003348A2 (en) | pharmaceutically acceptable compound or salt thereof, pharmaceutical composition and uses of effective amount of the pharmaceutically acceptable compound or salt thereof or pharmaceutical composition | |
WO2014059232A3 (en) | Substituted spiropiperidinyl compounds useful as gpr120 agonists | |
EA201071298A1 (en) | COMPOUND 3-AMINOCARBAZOLE, PHARMACEUTICAL COMPOSITION, CONTAINING IT, AND METHOD OF THEIR PREPARATION | |
RU2014151565A (en) | METHOD FOR PRODUCING N- [5- (3,5-DIFLUORBENZYL) -1H-INDAZOL-3-IL] -4- (4-METHYLPIPERAZIN-1-IL) -2- (TETHYROPYRAN-4-ILAMINO) BENZAMIDE | |
EA201590653A1 (en) | THERAPEUTIC TOOL FOR DYSLIPIDEMIA | |
JP2014507455A5 (en) | ||
EA201491335A1 (en) | BIGUANID COMPOSITIONS AND METHODS OF TREATMENT OF METABOLIC DISORDERS | |
JP2016510323A5 (en) | ||
EP2607363A4 (en) | Fused ring compound for use as mineralocorticoid receptor antagonist | |
JP2020519654A5 (en) | ||
RU2017131354A (en) | SUBSTITUTED AMINO HEXATURAL SATURATED HETEROALICYCLES AS LONG-TERM DPP-IV INHIBITORS | |
RU2015134420A (en) | CRYSTAL FORMS of {[1-CYANO-5- (4-CHLOROPHENOXIDE) -4-HYDROXIDE-Isoquinoline-3-CARBONIL] -AMINO} -ACETRIC ACID | |
RU2012136148A (en) | NEW CRYSTAL FORM OF THE CYCLOPROPYLBENZAMIDE DERIVATIVE | |
RU2013103754A (en) | NEW CRYSTAL FORMS N - [- 2 [[(2,3, -DIFLUORPHENYL) METHYL] THIO] -6 - {[((1R, 2S) -2,3-DYHYDROXY-1-METHYLPROPYL] OXY} -4-Pyrimidinyl] -1-Azatidine Sulfonamide | |
JP2013523623A5 (en) | ||
RU2013127611A (en) | Glucagon receptor modulators | |
RU2022111461A (en) | SODIUM BENZOATE CO-CRYSTALS AND THEIR APPLICATIONS | |
BR112022009705A2 (en) | CRYSTALLINE DRIVER FORM OF A 7H-BENZO[7]ANULENE-2-CARBOXYLIC ACID DERIVATIVE, ITS USES AND PREPARATION PROCESSES, SOLID FORM, DRUG AND PHARMACEUTICAL COMPOSITION | |
RU2012136457A (en) | NEW COMPOSITIONS FOR REDUCING AB 42 SYNTHESIS AND THEIR APPLICATION IN TREATMENT OF ALZHEIMER'S DISEASE (AD) |